Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$11.69
+4.7%
$11.66
$9.30
$25.36
$543.37M1.12795,838 shs465,995 shs
Bioventus Inc. stock logo
BVS
Bioventus
$7.64
+7.9%
$6.80
$5.81
$14.38
$631.67M0.83399,140 shs603,873 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$12.90
+3.4%
$12.85
$3.80
$17.31
$153.96M0.556,653 shs60,540 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.95
+0.1%
$13.99
$8.15
$19.00
$534.41M2.2551,395 shs313,527 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.00%+4.55%-1.76%-5.08%-49.64%
Bioventus Inc. stock logo
BVS
Bioventus
0.00%+3.66%+19.38%+17.00%-16.23%
LENSAR, Inc. stock logo
LNSR
LENSAR
0.00%+1.98%-0.23%-4.87%+187.95%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%+0.53%+1.17%+128.86%+9.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3.2856 of 5 stars
0.03.00.00.03.23.32.5
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
0.997 of 5 stars
2.01.00.00.02.62.50.0
ZimVie Inc. stock logo
ZIMV
ZimVie
0.6702 of 5 stars
1.03.00.00.02.71.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.00
HoldN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
2.75
Moderate Buy$13.7579.97% Upside
LENSAR, Inc. stock logo
LNSR
LENSAR
2.00
Hold$15.0016.28% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-6.33% Downside

Current Analyst Ratings Breakdown

Latest LNSR, BVS, ZIMV, and AVNS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$9.00 ➝ $19.00
7/7/2025
Bioventus Inc. stock logo
BVS
Bioventus
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$12.00
(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$687.80M0.79$11.81 per share0.99$16.73 per share0.70
Bioventus Inc. stock logo
BVS
Bioventus
$564.14M1.12$0.61 per share12.58$2.80 per share2.73
LENSAR, Inc. stock logo
LNSR
LENSAR
$53.49M2.88N/AN/A($1.93) per share-6.68
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.86 per share10.20$14.64 per share1.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$392.10M-$10.07N/A6.76N/A-66.89%6.16%4.57%10/29/2025 (Estimated)
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23MN/AN/A16.61N/A-7.11%15.61%4.01%N/A
LENSAR, Inc. stock logo
LNSR
LENSAR
-$31.40M-$4.21N/AN/A-84.49%-737.30%-72.60%11/6/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%10/29/2025 (Estimated)

Latest LNSR, BVS, ZIMV, and AVNS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.0750-$0.15-$0.0750-$0.15$16.55 million$11.36 million
8/5/2025Q2 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.18$0.17-$0.01-$1.66$165.50 million$175.00 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2080$0.26+$0.0520-$0.14$112.60 million$116.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.12
2.64
1.58
Bioventus Inc. stock logo
BVS
Bioventus
1.85
1.41
0.99
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
1.52
0.88
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.64%
Bioventus Inc. stock logo
BVS
Bioventus
33.00%
LENSAR, Inc. stock logo
LNSR
LENSAR
38.52%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2,22746.40 million45.18 millionOptionable
Bioventus Inc. stock logo
BVS
Bioventus
1,20082.68 million54.46 millionNot Optionable
LENSAR, Inc. stock logo
LNSR
LENSAR
11011.94 million7.34 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.20 million27.35 millionOptionable

Recent News About These Companies

Short Interest in ZimVie Inc. (NASDAQ:ZIMV) Expands By 26.1%
ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$11.69 +0.53 (+4.74%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$11.70 +0.02 (+0.14%)
As of 08/22/2025 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Bioventus stock logo

Bioventus NYSE:BVS

$7.64 +0.56 (+7.91%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$7.64 0.00 (-0.07%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

LENSAR stock logo

LENSAR NASDAQ:LNSR

$12.90 +0.43 (+3.45%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$12.90 0.00 (0.00%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.95 +0.02 (+0.11%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$18.90 -0.04 (-0.24%)
As of 08/22/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.